EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Exploring Cardiovascular Risk Factors and Atherosclerosis in Rheumatoid Arthritis

Alexandros A Drosos, Aliki A Venetsanopoulou, Eleftherios Pelechas, Paraskevi V Voulgari

European Journal of Internal Medicine · 2024

DOI: 10.1016/j.ejim.2024.07.016 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Internal Medicine, 2024. Verfasst von Alexandros A Drosos und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, School of Health Sciences, Faculty of Medicine, University of Ioannina, Ioannina, Greece. Electronic address: adrosos@uoi…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Atherosclerosis, Heart Disease Risk Factors, Dyslipidemias. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 101 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is a chronic inflammatory disease mainly affecting the peripheral diarthrodial joints symmetrically and also presenting many extra-articular manifestations. Morbidity and mortality in RA patients are higher compared to the general population. Cardiovascular (CV) disease is one of the most common causes of death in these patients. Classical or traditional risk factors for atherosclerosis development occur more frequently in RA patients compared to those without this condition. Studies have showed that RA patients often present comorbidities such as hypertension, dyslipidemia, diabetes mellitus and obesity. However, the high incidence of CV events occurring in RA patients is not explained by the presence of traditional risk factors. Systemic inflammation, as it is expressed with the presence of proinflammatory cytokines and increased acute phase reactants, may contribute to the development of premature atherosclerosis in these patients. In this review, we explore the risk factors for CV disease, the generation of dyslipidemia, the lipid paradox and the role of systemic inflammation in the atherosclerotic process in RA. We discuss also the role of early therapeutic intervention that suppresses inflammation which may have beneficial effects on CV disease in RA patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidAtherosclerosisHeart Disease Risk FactorsDyslipidemiasCardiovascular DiseasesHumansInflammationRisk Factors

Stichwörter der Autor:innen

Biological therapiesCardiovascular diseaseCoronary diseaseLipid paradoxRASystemic inflammation

Autor:innen und Institutionen

  • Department of Rheumatology, School of Health Sciences, Faculty of Medicine, University of Ioannina, Ioannina, Greece. Electronic address: adrosos@uoi.gr.
  • Department of Rheumatology, School of Health Sciences, Faculty of Medicine, University of Ioannina, Ioannina, Greece.

Zitieren

APA

Drosos, A. A., Venetsanopoulou, A. A., Pelechas, E., & Voulgari, P. V. (2024). Exploring Cardiovascular Risk Factors and Atherosclerosis in Rheumatoid Arthritis. European Journal of Internal Medicine. https://doi.org/10.1016/j.ejim.2024.07.016

Vancouver

Drosos AA, Venetsanopoulou AA, Pelechas E, Voulgari PV. Exploring Cardiovascular Risk Factors and Atherosclerosis in Rheumatoid Arthritis. European Journal of Internal Medicine. 2024. doi:10.1016/j.ejim.2024.07.016

BibTeX
@article{Drosos2024,
  author = {Drosos, Alexandros A and Venetsanopoulou, Aliki A and Pelechas, Eleftherios and Voulgari, Paraskevi V},
  title = {Exploring Cardiovascular Risk Factors and Atherosclerosis in Rheumatoid Arthritis},
  journal = {European Journal of Internal Medicine},
  year = {2024},
  doi = {10.1016/j.ejim.2024.07.016}
}
Kostenlos starten →